Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Hillaire, Marine L B ^a   Osterhaus, Albert D M E ^a,b   Rimmelzwaan, Guus F ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Viroclinics Biosciences BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA VACCINE; EPITOPE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIVE VACCINE; NUCLEOPROTEIN; PARVOVIRUS VECTOR; VIROSOME; VIROSOME VACCINE;

ADOPTIVE TRANSFER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS H2N1; NONHUMAN; REVIEW; SEASONAL INFLUENZA; CROSS PROTECTION; IMMUNOLOGY; METABOLISM; ORTHOMYXOVIRUS; PATHOGENICITY; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

CROSS PROTECTION; CROSS REACTIONS; EPITOPES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 84855175221     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/939860     Document Type: Review

References (158)

1. de Jong J. C., Palache A. M., Beyer W. E., Rimmelzwaan G. F., Boon A. C., Osterhaus A. D., Haemagglutination-inhibiting antibody to influenza virus Developments in Biologicals 2003 115 63 73
2. Food and Drug Administration guidance for industry, http://www.fda.gov/ downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/Vaccines/ucm092272.pdf
3. The European Agency for the Evaluation of Medical Products, Note for guidance on harmonisation of requirements for influenza vaccines 1997
4. Abelin A., Colegate T., Gardner S., Hehme N., Palache A., Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective Vaccine 2010 29 6 1135 1138
5. Butler D., Portrait of a year-old pandemic Nature 2010 464 7292 1112 1113
6. Epstein S. L., Price G. E., Cross-protective immunity to influenza A viruses Expert Review of Vaccines 2010 9 11 1325 1341
7. Stephenson I., Hayden F., Osterhaus A., Howard W., Pervikov Y., Palkonyay L., Kieny M. P., Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 november 2009 Vaccine 2010 28 23 3875 3882
8. Grebe K. M., Yewdell J. W., Bennink J. R., Heterosubtypic immunity to influenza A virus: where do we stand? Microbes and Infection 2008 10 9 1024 1029
9. Corti D., Suguitan A. L. Jr., Pinna D., Silacci C., Fernandez-Rodriguez B. M., Vanzetta F., Santos C., Luke C. J., Torres-Velez F. J., Temperton N. J., Weiss R. A., Sallusto F., Subbarao K., Lanzavecchia A., Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine Journal of Clinical Investigation 2010 120 5 1663 1673
10. Ekiert D. C., Bhabha G., Elsliger M. A., Friesen R. H., Jongeneelen M., Throsby M., Goudsmit J., Wilson I. A., Antibody recognition of a highly conserved influenza virus epitope Science 2009 324 5924 246 251
11. Steel J., Lowen A. C., Wang T. T., Yondola M., Gao Q., Haye K., Garca-Sastre A., Palesea P., Influenza virus vaccine based on the conserved hemagglutinin stalk domain MBio 2010 1 1
12. Wang T. T., Tan G. S., Hai R., Pica N., Ngai L., Ekiert D. C., Wilson I. A., Garca-Sastre A., Moran T. M., Palese P., Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes Proceedings of the National Academy of Sciences of the United States of America 2010 107 44 18979 18984
13. Wei C. J., Boyington J. C., McTamney P. M., Kong W. P., Pearce M. B., Xu L., Andersen H., Rao S., Tumpey T. M., Yang Z. Y., Nabel G. J., Induction of broadly neutralizing H1N1 influenza antibodies by vaccination Science 2010 329 5995 1060 1064
14. Okuno Y., Isegawa Y., Sasao F., Ueda S., A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains Journal of Virology 1993 67 5 2552 2558 (Pubitemid 23118850)
15. Smirnov Y. A., Lipatov A. S., Gitelman A. K., Okuno Y., van Beek R., Osterhaus A. D., Claas E. C., An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus Acta Virologica 1999 43 4 237 244 (Pubitemid 29430389)
16. Friesen R. H., Koudstaal W., Koldijk M. H., Weverling G. J., Brakenhoff J. P., Lenting P. J., Stittelaar K. J., Osterhaus A. D., Kompier R., Goudsmit J., New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets PLoS ONE 2010 5 2
17. Fan J., Liang X., Horton M. S., Perry H. C., Citron M. P., Heidecker G. J., Fu T. M., Joyce J., Przysiecki C. T., Keller P. M., Garsky V. M., Ionescu R., Rippeon Y., Shi L., Chastain M. A., Condra J. H., Davies M. E., Liao J., Emini E. A., Shiver J. W., Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys Vaccine 2004 22 23-24 2993 3003 (Pubitemid 39037199)
18. Heinen P. P., Rijsewijks F. A., de Boer-Luitjtze E. A., Bianchi A. T., Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus Journal of General Virology 2002 83 8 1851 1859 (Pubitemid 34846448)
19. Slepushkin V. A., Katz J. M., Black R. A., Gamble W. C., Rota P. A., Cox N. J., Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein Vaccine 1995 13 15 1399 1402
20. Song J. M., Wang B. Z., Park K. M., van Rooijen N., Quan F. S., Kim M. C., Jin H. T., Pekosz A., Compans R. W., Kang S. M., Influenza virus-like particles containing M2 induce broadly cross protective immunity PLoS ONE 2011 6 1
21. Tompkins S. M., Zhao Z. S., Lo C. Y., Misplon J. A., Liu T., Ye Z., Hogan R. J., Wu Z., Benton K. A., Tumpey T. M., Epstein S. L., Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1 Emerging Infectious Diseases 2007 13 3 426 435 (Pubitemid 46348126)
22. Hillaire M. L. B., van Trierum S. E., Kreijtz J. H. C. M., Bodewes R., Geelhoed-Mieras M. M., Nieuwkoop N. J., Fouchier R. A. M., Kuiken T., Osterhaus A. D. M. E., Rimmelzwaan G. F., Cross-protective immunity against influenza pH 1 N 1 2009 viruses induced by seasonal influenza A (H 3 N 2) virus is mediated by virus-specific T-cells Journal of General Virology 2011 92 10 2339 2349
23. Jegerlehner A., Schmitz N., Storni T., Bachmann M. F., Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity Journal of Immunology 2004 172 9 5598 5605 (Pubitemid 38542062)
24. Effros R. B., Doherty P. C., Gerhard W., Bennink J., Generation of both cross reactive and virus specific T-cell populations after immunization with serologically distinct influenza A viruses Journal of Experimental Medicine 1977 145 3 557 568 (Pubitemid 8049609)
25. Yap K. L., Ada G. L., McKenzie I. F., Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus Nature 1978 273 5659 238 239 (Pubitemid 8331715)
26. Jung S., Unutmaz D., Wong P., Sano G., de Los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., Pamer E. G., Littman D. R., Lang R. A., In Vivo depletion of CD11c + dendritic cells abrogates priming of CD8 + T cells by exogenous cell-associated antigens Immunity 2002 17 2 211 220 (Pubitemid 35245963)
27. Zammit D. J., Cauley L. S., Pham Q. M., Lefranois L., Dendritic cells maximize the memory CD8 T cell response to infection Immunity 2005 22 5 561 570 (Pubitemid 40719192)
28. Zweerink H. J., Courtneidge S. A., Skehel J. J., Crumpton M. J., Askonas B. A., Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses Nature 1977 267 5609 354 356 (Pubitemid 8119786)
29. Yewdell J. W., Bennink J. R., Smith G. L., Moss B., Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes Proceedings of the National Academy of Sciences of the United States of America 1985 82 6 1785 1789 (Pubitemid 15085262)
30. Kees U., Krammer P. H., Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants Journal of Experimental Medicine 1984 159 2 365 377 (Pubitemid 14193982)
31. Gotch F., McMichael A., Smith G., Moss B., Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes Journal of Experimental Medicine 1987 165 2 408 416 (Pubitemid 17019824)
32. Lee L. Y., Ha Do L. A., Simmons C., de Jong M. D., Chau N. V., Schumacher R., Peng Y. C., McMichael A. J., Farrar J. J., Smith G. L., Townsend A. R., Askonas B. A., Rowland-Jones S., Dong T., Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals Journal of Clinical Investigation 2008 118 10 3478 3490
33. Kreijtz J. H., de Mutsert G., van Baalen C. A., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus Journal of Virology 2008 82 11 5161 5166 (Pubitemid 351705225)
34. Jameson J., Cruz J., Terajima M., Ennis F. A., Human CD8 + and CD4 + T lymphocyte memory to influenza a viruses of swine and avian species Journal of Immunology 1999 162 12 7578 7583 (Pubitemid 29277740)
35. Gras S., Kedzierski L., Valkenburg S. A., Laurie K., Liu Y. C., Denholm J. T., Richards M. J., Rimmelzwaan G. F., Kelso A., Doherty P. C., Turner S. J., Rossjohn J., Kedzierska K., Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses Proceedings of the National Academy of Sciences of the United States of America 2010 107 28 12599 12604
36. Tu W., Mao H., Zheng J., Liu Y., Chiu S. S., Qin G., Chan P. L., Lam K. T., Guan J., Zhang L., Guan Y., Yuen K. Y., Peiris J. S. M., Lau Y. L., Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus Journal of Virology 2010 84 13 6527 6535
37. McMichael A. J., Gotch F. M., Noble G. R., Beare P. A., Cytotoxic T-cell immunity to influenza New England Journal of Medicine 1983 309 1 13 17 (Pubitemid 13062888)
38. McMichael A. J., Michie C. A., Gotch F. M., Smith G. L., Moss B., Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes Journal of General Virology 1986 67 4 719 726 (Pubitemid 16048050)
39. Townsend A. R. M., Skehel J. J., The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells Journal of Experimental Medicine 1984 160 2 552 563 (Pubitemid 14052516)
40. Zweerink H. J., Askonas B. A., Millican D., Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity European Journal of Immunology 1977 7 9 630 635 (Pubitemid 8200514)
41. Smallman-Raynor M., Cliff A. D., Avian influenza A (H5N1) age distribution in humans Emerging Infectious Diseases 2007 13 3 510 512 (Pubitemid 46348146)
42. Kreijtz J. H., Bodewes R., van den Brand J. M., de Mutsert G., Baas C., van Amerongen G., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus Vaccine 2009 27 36 4983 4989
43. Kreijtz J. H., Bodewes R., van Amerongen G., Kuiken T., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice Vaccine 2007 25 4 612 620 (Pubitemid 44856111)
44. Benton K. A., Misplon J. A., Lo C. Y., Brutkiewicz R. R., Prasad S. A., Epstein S. L., Heterosubtypic immunity to influenza a virus in mice lacking IgA, all Ig, NKT cells, or T cells Journal of Immunology 2001 166 12 7437 7445 (Pubitemid 32525621)
45. Nguyen H. H., Moldoveanu Z., Novak M. J., van Ginkel F. W., Ban E., Kiyono H., McGhee J. R., Mestecky J., Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8 + cytotoxic T lymphocyte responses induced in mucosa-associated tissues Virology 1999 254 1 50 60 (Pubitemid 29391713)
46. O'Neill E., Krauss S. L., Riberdy J. M., Webster R. G., Woodland D. L., Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice Journal of General Virology 2000 81 11 2689 2696
47. Schulman J. L., Kilbourne E. D., Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus Journal of Bacteriology 1965 89 1 170 174
48. Yap K. L., Ada G. L., The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus specific cytotoxic T lymphocytes recognizing a common virion antigen Scandinavian Journal of Immunology 1978 8 5 413 420 (Pubitemid 9070619)
49. Wells M. A., Ennis F. A., Albrecht P., Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia Journal of Immunology 1981 126 3 1042 1046 (Pubitemid 11155752)
50. Taylor P. M., Askonas B. A., Influenza nucleoprotein-specific cytotoxic T-cell clones are protective In Vivo Immunology 1986 58 3 417 420 (Pubitemid 16097640)
51. Wraith D. C., Vessey A. E., Askonas B. A., Purified influenza virus nucleoprotein protects mice from lethal infection Journal of General Virology 1987 68 2 433 440 (Pubitemid 17007830)
52. Lukacher A. E., Braciale V. L., Braciale T. J., In Vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific Journal of Experimental Medicine 1984 160 3 814 826 (Pubitemid 14074780)
53. Askonas B. A., Taylor P. M., Esquivel F., Cytotoxic T cells in influenza infection Annals of the New York Academy of Sciences 1988 532 230 237 (Pubitemid 19017643)
54. Liang S., Mozdzanowska K., Palladino G., Gerhard W., Heterosubtypic immunity to influenza type A virus in mice: effector mechanisms and their longevity Journal of Immunology 1994 152 4 1653 1661 (Pubitemid 24075695)
55. Guo H., Santiago F., Lambert K., Takimoto T., Topham D. J., T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model Journal of Virology 2011 85 1 448 455
56. Seo S. H., Webster R. G., Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets Journal of Virology 2001 75 6 2516 2525 (Pubitemid 32185015)
57. Seo S. H., Peiris M., Webster R. G., Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8 + T cells expressing interferon Journal of Virology 2002 76 10 4886 4890 (Pubitemid 34441694)
58. Bodewes R., Kreijtz J. H., Geelhoed-Mieras M. M., van Amerongen G., verburgh R. J., van Trierum S. E., Kuiken T., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets Journal of Virology 2011 85 6 2695 2702
59. Skountzou I., Koutsonanos D. G., Kim J. H., Powers R., Satyabhama L., Masseoud F., Weldon W. C., Martin M. P., Mittler R. S., Compans R., Jacob J., Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 a (H1N1) influenza virus Journal of Immunology 2010 185 3 1642 1649
60. Epstein S. L., Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature Journal of Infectious Diseases 2006 193 1 49 53 (Pubitemid 43032498)
61. Berkhoff E. G., Geelhoed-Mieras M. M., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8 + T-cell clones Journal of General Virology 2007 88 2 530 535 (Pubitemid 46210892)
62. Voeten J. T., Bestebroer T. M., Nieuwkoop N. J., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Antigenic drift in the influenza a virus (H3N2) Nucleoprotein and escape from recognition by cytotoxic T lymphocytes Journal of Virology 2000 74 15 6800 6807 (Pubitemid 30470663)
63. Boon A. C. M., de Mutsert G., Graus Y. M., Fouchier R. A., Sintnicolaas K., Osterhaus A. D., Rimmelzwaan G. F., Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes Journal of Virology 2002 76 5 2567 2572 (Pubitemid 34150727)
64. Rimmelzwaan G. F., Boon A. C., Voeten J. T., Berkhoff E. G., Fouchier R. A., Osterhaus A. D., Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes Virus Research 2004 103 1-2 97 100 (Pubitemid 38649067)
65. Boon A. C., de Mutsert G., Van Baarle D., Smith D. J., Lapedes A. S., Fouchier R. A., Sintnicolaas K., Osterhaus A. D., Rimmelzwaan G. F., Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8 + T Lymphocytes Journal of Immunology 2004 172 4 2453 2460 (Pubitemid 38182395)
66. Berkhoff E. G., Boon A. C., Nieuwkoop N. J., Fouchier R. A., Sintnicolaas K., Osterhaus A. D., Rimmelzwaan G. F., A mutation in the HLA-B -restricted NP 383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro Journal of Virology 2004 78 10 5216 5222 (Pubitemid 38581473)
67. Berkhoff E. G., Geelhoed-Mieras M. M., Verschuren E. J., van Baalen C. A., Gruters R. A., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., The loss of immunodominant epitopes affects interferon- production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro Clinical and Experimental Immunology 2007 148 2 296 306 (Pubitemid 46587587)
68. Rimmelzwaan G. F., Berkhoff E. G., Nieuwkoop N. J., Fouchier R. A., Osterhaus A. D., Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza A viruses by comutations Journal of Virology 2004 78 16 8946 8949 (Pubitemid 39025163)
69. Rimmelzwaan G. F., Berkhoff E. G., Nieuwkoop N. J., Smith D. J., Fouchier R. A., Osterhaus A. D., Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants Journal of General Virology 2005 86 6 1801 1805 (Pubitemid 40766893)
70. Gog J. R., Rimmelzwaan G. F., Osterhaus A. D., Grenfell B. T., Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A Proceedings of the National Academy of Sciences of the United States of America 2003 100 19 11143 11147 (Pubitemid 37140166)
71. Berkhoff E. G., de Wit E., Geelhoed-Mieras M. M., Boon A. C., Symons J., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes Journal of Virology 2005 79 17 11239 11246 (Pubitemid 41170666)
72. Berkhoff E. G., de Wit E., Geelhoed-Mieras M. M., Boon A. C., Symons J., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses Vaccine 2006 24 4446 6594 6596 (Pubitemid 46107162)
73. Yewdell J. W., Bennink J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses Annual Review of Immunology 1999 17 51 88 (Pubitemid 29241119)
74. Yewdell J. W., Del Val M., Immunodominance in TCD8 + responses to viruses: cell biology, cellular immunology, and mathematical models Immunity 2004 21 2 149 153 (Pubitemid 39094045)
75. Yewdell J. W., Confronting complexity: real-world immunodominance in antiviral CD8 + T cell responses Immunity 2006 25 4 533 543 (Pubitemid 44529047)
76. Chen W., Pang K., Masterman K. A., Kennedy G., Basta S., Dimopoulos N., Hornung F., Smyth M., Bennink J. R., Yewdell J. W., Reversal in the immunodominance hierarchy in secondary CD8 + T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination Journal of Immunology 2004 173 8 5021 5027 (Pubitemid 39387784)
77. Boon A. C., de Mutsert G., Graus Y. M., Fouchier R. A., Sintnicolaas K., Rimmelzwaan A. D., Osterhaus G. F., The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype Journal of Virology 2002 76 2 582 590 (Pubitemid 34033357)
78. Belz G. T., Xie W., Altman J. D., Doherty P. C., A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza a virus-specific CD8 + T-cell response is much less apparent following secondary challenge Journal of Virology 2000 74 8 3486 3493 (Pubitemid 30180290)
79. Belz G. T., Stevenson P. G., Doherty P. C., Contemporary analysis of MHC-related immunodominance hierarchies in the CD8 + T cell response to influenza A viruses Journal of Immunology 2000 165 5 2404 2409 (Pubitemid 30660683)
80. Boon A. C., de Mutsert G., Fouchier R. A., Sintnicolaas K., Osterhaus A. D., Rimmelzwaan G. F., Preferential HLA usage in the influenza virus-specific CTL response Journal of Immunology 2004 172 7 4435 4443 (Pubitemid 38375259)
81. Tussey L. G., Rowland-Jones S., Zheng T. S., Androlewicz M. J., Cresswell P., Frelinger J. A., McMichael A. J., Different MHC class I alleles compete for presentation of overlapping viral epitopes Immunity 1995 3 1 65 77
82. Cho Y., Basta S., Chen W., Bennink J. R., Yewdell J. W., Heat-aggregated noninfectious influenza virus induces a more balanced CD8 + -T-lymphocyte immunodominance hierarchy than infectious virus Journal of Virology 2003 77 8 4679 4684 (Pubitemid 36402817)
83. Cui W., Kaech S. M., Generation of effector CD8 + T cells and their conversion to memory T cells Immunological Reviews 2010 236 1 151 166
84. Schanen B. C., de Groot A. S., Moise L., Ardito M., McClaine E., Martin W., Wittman V., Warren W. L., Drake D. R. III, Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4 + T cells against the swine-origin H1N1 influenza virus Vaccine 2011 29 17 3299 3309
85. Roti M., Yang J., Berger D., Huston L., James E. A., Kwok W. W., Healthy human subjects have CD4 + T cells directed against H5N1 influenza virus Journal of Immunology 2008 180 3 1758 1768
86. Carragher D. M., Kaminski D. A., Moquin A., Hartson L., Randall T. D., A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus Journal of Immunology 2008 181 6 4168 4176
87. Nguyen H. H., van Ginkel F. W., Vu H. L., McGhee J. R., Mestecky J., Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8 + cytotoxic T lymphocytes Journal of Infectious Diseases 2001 183 3 368 376 (Pubitemid 32105595)
88. Epstein S. L., Lo C. Y., Misplon J. A., Lawson C. M., Hendrickson B. A., Max E. E., Subbarao K., Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, 2-microglobulin-deficient, and J chain-deficient mice Journal of Immunology 1997 158 3 1222 1230 (Pubitemid 127469945)
89. Throsby M., van den Brink E., Jongeneelen M., Poon L. L., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E., Guan Y., Cinatl J., ter Meulen J., Lasters I., Carsetti R., Peiris M., de Kruif J., Goudsmit J., Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM + memory B cells PLoS ONE 2008 3 12
90. Rangel-Moreno J., Carragher D. M., Misra R. S., Kusser K., Hartson L., Moquin A., Lund F. E., Randall T. D., B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms Journal of Immunology 2008 180 1 454 463
91. Gorse G. J., Belshe R. B., Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults Journal of Clinical Microbiology 1990 28 11 2539 2550 (Pubitemid 20353536)
92. Gorse G. J., Belshe R. B., Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses Scandinavian Journal of Infectious Diseases 1991 23 1 7 17
93. Gorse G. J., Campbell M. J., Otto E. E., Powers D. C., Chambers G. W., Newman F. K., Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine Journal of Infectious Diseases 1995 172 1 1 10
94. Basha S., Hazenfeld S., Brady R. C., Subbramanian R. A., Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin Human Immunology 2011 72 6 463 469
95. He X. S., Holmes T. H., Zhang C., Mahmood K., Kemble G. W., Lewis D. B., Dekker C. L., Greenberg H. B., Arvin A. M., Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines Journal of Virology 2006 80 23 11756 11766 (Pubitemid 44788888)
96. Powell T. J., Strutt T., Reome J., Hollenbaugh J. A., Roberts A. D., Woodland D. L., Swain S. L., Dutton R. W., Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus Journal of Immunology 2007 178 2 1030 1038 (Pubitemid 46095176)
97. Chen G. L., Lau Y. F., Lamirande E. W., McCall A. W., Subbarao K., Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine Proceedings of the National Academy of Sciences of the United States of America 2011 108 3 1140 1145
98. Sun K., Ye J., Perez D. R., Metzger D. W., Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections Journal of Immunology 2011 186 2 987 993
99. Lu X., Edwards L. E., Desheva J. A., Nguyen D. C., Rekstin A., Stephenson I., Szretter K., Cox N. J., Rudenko L. G., Klimov A., Katz J. M., Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses Vaccine 2006 24 4446 6588 6593 (Pubitemid 46107146)
100. Garca-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T., Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems Virology 1998 252 2 324 330 (Pubitemid 29013414)
101. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A. A., Garca-Sastre A., Influenza A virus NS1 protein prevents activation of NF- B and induction of /interferon Journal of Virology 2000 74 24 11566 11573 (Pubitemid 32222305)
102. Donelan N. R., Basler C. F., Garca-Sastre A., A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of interferon and is attenuated in mice Journal of Virology 2003 77 24 13257 13266 (Pubitemid 37494321)
103. Mueller S. N., Langley W. A., Carnero E., Garca-Sastre A., Ahmed R., Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8 + T-cell responses Journal of Virology 2010 84 4 1847 1855
104. Xie H., Liu T. M., Lu X., Wu Z., Belser J. A., Katz J. M., Tumpey T. M., Ye Z., A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in Mice Journal of Infectious Diseases 2009 200 12 1874 1883
105. Ulmer J. B., Influenza DNA vaccines Vaccine 2002 20 supplement 2 S74 S76
106. Moss R. B., Prospects for control of emerging infectious diseases with plasmid DNA vaccines Journal of Immune Based Therapies and Vaccines 2009 7 3
107. Laddy D. J., Weiner D. B., From plasmids to protection: a review of DNA vaccines against infectious diseases International Reviews of Immunology 2006 25 3-4 99 123
108. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A., Hawe L. A., Leander K. R., Martinez D., Perry H. C., Shiver J. W., Montgomery D. L., Liu M. A., Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259 5102 1745 1749 (Pubitemid 23114660)
109. Tao P., Luo M., Pan R., Ling D., Zhou S., Tien P., Pan Z., Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice Antiviral Research 2009 81 3 253 260
110. Donnelly J. J., Friedman A., Ulmer J. B., Liu M. A., Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination Vaccine 1997 15 8 865 868 (Pubitemid 27287977)
111. Ulmer J. B., Fu T. M., Deck R. R., Friedman A., Guan L., DeWitt C., Liu X., Wang S., Liu M. A., Donnelly J. J., Caulfield M. J., Protective CD4 + and CD8 + T cells against influenza virus induced by vaccination with nucleoprotein DNA Journal of Virology 1998 72 7 5648 5653 (Pubitemid 28283349)
112. Fu T. M., Guan L., Friedman A., Schofield T. L., Ulmer J. B., Liu M. A., Donnelly J. J., Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge Journal of Immunology 1999 162 7 4163 4170 (Pubitemid 29314802)
113. Ulmer J. B., Deck R. R., Dewitt C. M., Donnelly J. J., Liu M. A., Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells Immunology 1996 89 1 59 67 (Pubitemid 26284039)
114. Saha S., Yoshida S., Ohba K., Matsui K., Matsuda T., Takeshita F., Umeda K., Tamura Y., Okuda K., Klinman D., Xin K. Q., Okuda K., A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus Virology 2006 354 1 48 57 (Pubitemid 44441505)
115. Laddy D. J., Yan J., Kutzler M., Kobasa D., Kobinger G. P., Khan A. S., Greenhouse J., Sardesai N. Y., Draghia-Akli R., Weiner D. B., Heterosubtypic protection against pathogenic human and avian influenza viruses via In Vivo electroporation of synthetic consensus DNA antigens PLoS ONE 2008 3 6
116. Smith L. R., Wloch M. K., Ye M., Reyes L. R., Boutsaboualoy S., Dunne C. E., Chaplin J. A., Rusalov D., Rolland A. P., Fisher C. L., Al-Ibrahim M. S., Kabongo M. L., Steigbigel R., Belshe R. B., Kitt E. R., Chu A. H., Moss R. B., Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin Vaccine 2010 28 13 2565 2572
117. Klinman D. M., Takeno M., Ichino M., Gu M., Yamshchikov G., Mor G., Conover J., DNA vaccines: safety and efficacy issues Springer Seminars in Immunopathology 1997 19 2 245 256 (Pubitemid 27477895)
118. Chen C. Y., Liu H. J., Tsai C. P., Chung C. Y., Shih Y. S., Chang P. C., Chiu Y. T., Hu Y. C., Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms Vaccine 2010 28 48 7644 7651
119. Barefoot B. E., Sample C. J., Ramsburg E. A., Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus Clinical and Vaccine Immunology 2009 16 4 488 498
120. Barefoot B. E., Athearn K., Sample C. J., Ramsburg E. A., Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge Vaccine 2009 28 1 79 89
121. Berglund P., Fleeton M. N., Smerdou C., Liljestrm P., Immunization with recombinant semliki forest virus induces protection against influenza challenge in mice Vaccine 1999 17 5 497 507 (Pubitemid 29064008)
122. Vemula S. V., Mittal S. K., Production of adenovirus vectors and their use as a delivery system for influenza vaccines Expert Opinion on Biological Therapy 2010 10 10 1469 1487
123. He F., Madhan S., Kwang J., Baculovirus vector as a delivery vehicle for influenza vaccines Expert Review of Vaccines 2009 8 4 455 467
124. Rimmelzwaan G. F., Sutter G., Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara Expert Review of Vaccines 2009 8 4 447 454
125. Hoelscher M. A., Singh N., Garg S., Jayashankar L., Veguilla V., Pandey A., Matsuoka Y., Katz J. M., Donis R., Mittal S. K., Sambhara S., A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses Journal of Infectious Diseases 2008 197 8 1185 1188 (Pubitemid 351590054)
126. Holman D. H., Wang D., Raja N. U., Luo M., Moore K. M., Woraratanadharm J., Mytle N., Dong J. Y., Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses Vaccine 2008 26 21 2627 2639
127. Prasad S. A., Norbury C. C., Chen W., Bennink J. R., Yewdell J. W., Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells Journal of Immunology 2001 166 8 4809 4812 (Pubitemid 32280685)
128. Roy S., Kobinger G. P., Lin J., Figueredo J., Calcedo R., Kobasa D., Wilson J. M., Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein Vaccine 2007 25 39-40 6845 6851 (Pubitemid 47398928)
129. Steitz J., Barlow P. G., Hossain J., Kim E., Okada K., Kenniston T., Rea S., Donis R. O., Gambotto A., A candidate H1N1 pandemic influenza vaccine elicits protective immunity in Mice PLoS ONE 2010 5 5
130. Hoelscher M. A., Jayashankar L., Garg S., Veguilla V., Lu X., Singh N., Katz J. M., Mittal S. K., Sambhara S., New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice Clinical Pharmacology and Therapeutics 2007 82 6 665 671 (Pubitemid 350114832)
131. Hoelscher M. A., Garg S., Bangari D. S., Belser J. A., Lu X., Stephenson I., Bright R. A., Katz J. M., Mittal S. K., Sambhara S., Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice The Lancet 2006 367 9509 475 481 (Pubitemid 43208903)
132. Gao W., Soloff A. C., Lu X., Montecalvo A., Nguyen D. C., Matsuoka Y., Robbins P. D., Swayne D. E., Donis R. O., Katz J. M., Barratt-Boyes S. M., Gambotto A., Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization Journal of Virology 2006 80 4 1959 1964 (Pubitemid 43228735)
133. Singh S., Toro H., Tang D. C., Briles W. E., Yates L. M., Kopulos R. T., Collisson E. W., Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8 + T lymphocytes Virology 2010 405 1 62 69
134. Sipo I., Knauf M., Fechner H., Poller W., Planz O., Kurth R., Norley S., Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV) Vaccine 2011 29 8 1690 1699
135. Kreijtz J. H., Suezer Y., de Mutsert G., van den Brand J. M. A., van Amerongen G., Schnierle B. S., Kuiken T., Fouchier R. A., Lwer J., Osterhaus A. D., Sutter G., Rimmelzwaan G. F., Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses Vaccine 2009 27 45 6296 6299
136. Kreijtz J. H., Suezer Y., de Mutsert G., van Amerongen G., Scwantes A., van den Brand J. M.A., Fouchier R. A.M., Lower J., Osterhaus A. D.M.E., Sutter G., Rimmelzwaan G. F., MVA-based H5N1 vaccine affords cross-clade protection in mice against influenz a A/H5N1 viruses at low doses and after single immunization PLoS ONE 2009 4 11
137. Kreijtz J. H., Suzer Y., Bodewes R., Schwantes A., van Amerongen G., Verburgh R. J., de Mutsert G., van den Brand J., van Trierum S. E., Kuiken T., Fouchier R. A., Osterhaus A. D., Sutter G., Rimmelzwaan G. F., Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model Journal of General Virology 2010 91 11 2745 2752
138. Sutter G., Wyatt L. S., Foley P. L., Bennink J. R., Moss B., A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus Vaccine 1994 12 11 1032 1040
139. Hessel A., Schwendinger M., Holzer G. W., Orlinger K. K., Coulibaly S., Savidis-Dacho H., Zips M. L., Crowe B. A., Kreil T. R., Ehrlich H. J., Barrett P. N., Falkner F. G., Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity PLoS ONE 2011 6 1
140. Breathnach C. C., Clark H. J., Clark R. C., Olsen C. W., Townsend H. G., Lunn D. P., Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge Vaccine 2006 24 8 1180 1190 (Pubitemid 43202264)
141. Berthoud T. K., Hamill M., Lillie P. J., Hwenda L., Collins K. A., Ewer K. J., Milicic A., Poyntz H. C., Lambe T., Fletcher H. A., Hill A. V.S., Gilbert S. C., Potent CD8 + T-cell immunogenicity in humans of a novel heterosubtypic influenza a vaccine, MVA-NP+M1 Clinical Infectious Diseases 2011 52 1 1 7
142. Galarza J. M., Latham T., Cupo A., Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge Viral Immunology 2005 18 1 244 251 (Pubitemid 40586463)
143. Layton G. T., Harris S. J., Myhan J., West D., Gotch F., Hill-Perkins M., Cole J. S., Meyers N., Woodrow S., French T. J., Adams S. E., Kingsman A. J., Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles Immunology 1996 87 2 171 178 (Pubitemid 26060586)
144. Ross T. M., Mahmood K., Crevar C. J., Schneider-Ohrum K., Heaton P. M., Bright R. A., A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets PLoS ONE 2009 4 6
145. Lee D. H., Park J. K., Lee Y. N., Song J. M., Kang S. M., Lee J. B., Park S. Y., Choi I. S., Song C. S., H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals Vaccine 2011 29 23 4003 4007
146. Furuya Y., Chan J., Regner M., Lobigs M., Koskinen A., Kok T., Manavis J., Li P., Mullbacher A., Alsharifi M., Cytotoxic T cells are the predominant players providing cross-protective immunity induced by -irradiated influenza A viruses Journal of Virology 2010 84 9 4212 4221
147. Morein B., Sundquist B., Hoglund S., Dalsgaard K., Osterhaus A., Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses Nature 1984 308 5958 457 460 (Pubitemid 14130919)
148. Voeten J. T., Rimmelzwaan G. F., Nieuwkoop N. J., Lvgren-Bengtsson K., Osterhaus A. D., Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8 + cytotoxic T lymphocytes Vaccine 2000 19 4-5 514 522
149. Sambhara S., Kurichh A., Miranda R., Tumpey T., Rowe T., Renshaw M., Arpino R., Tamane A., Kandil A., James O., Underdown B., Klein M., Katz J., Burt D., Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function Cellular Immunology 2001 211 2 143 153 (Pubitemid 32977345)
150. Glck R., Mischler R., Finkel B., Que J. U., Scarpa B., Cryz S. J. Jr., Immunogenicity of new virosome influenza vaccine in elderly people The Lancet 1994 344 8916 160 163 (Pubitemid 24218879)
151. Rimmelzwaan G. F., Nieuwkoop N., Brandenburg A., Sutter G., Beyer W. E., Maher D., Bates J., Osterhaus A. D., A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines Vaccine 2000 19 9-10 1180 1187 (Pubitemid 32010699)
152. Ennis F. A., Cruz J., Jameson J., Klein M., Burt D., Thipphawong J., Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS) Virology 1999 259 2 256 261 (Pubitemid 29393375)
153. Wilschut J., Influenza vaccines: the virosome concept Immunology Letters 2009 122 2 118 121
154. Bungener L., Huckriede A., de Mare A., de Vries-Idema J., Wilschut J., Daemen T., Virosome-mediated delivery of protein antigens In Vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity Vaccine 2005 23 10 1232 1241 (Pubitemid 40126526)
155. Bungener L., Serre K., Bijl L., Leserman L., Wilschut J., Daemen T., Machy P., Virosome-mediated delivery of protein antigens to dendritic cells Vaccine 2002 20 17-18 2287 2295 (Pubitemid 34497039)
156. Conne P., Gauthey L., Vernet P., Althaus B., Que J. U., Finkel B., Glck R., Cryz S. J. Jr., Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients Vaccine 1997 15 15 1675 1679 (Pubitemid 27445747)
157. Pregliasco F., Mensi C., Serpilli W., Speccher L., Masella P., Belloni A., Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly Aging 2001 13 1 38 43 (Pubitemid 32241877)
158. de Bruijn I. A., Nauta J., Gerez L., Palache A. M., The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad) in elderly subjects Vaccine 2006 24 4446 6629 6631 (Pubitemid 46107151)